- Federal IDR fee drops from $115 to $15: 6 things ASC and anesthesia leaders should know
- Specialty dentist pay by state, adjusted for cost of living
- Is value-based care now code for cost-cutting?
- The real cost of a bad anesthesia contract
- Georgia authorizes pharmacists to prescribe HIV prevention drugs
- From Adoption to Accountability: What AI Maturity Actually Demands of Hospital Leaders
- Behavioral health hospital operator to pay $32M in Medicare fraud settlement
- Crohn’s, colitis, IBS: GLP-1s’ next frontier?
- FIU, Baptist Health debut $158M outpatient medical center
- New hepatitis B drug shows cure potential
- Why physician groups are walking away from Medicare
- 10 hospitals, health systems seeking pharmacy leaders
- CVS reverses on Zepbound coverage amid lawsuit, patient backlash
- Children’s National names 4 leaders
- NYU Langone cuts nursing support staff turnover 40% in 8 months
- Samsung, Massachusetts General Hospital test wearable tech for GLP-1 patients
- Innovaccer acquires RCM company
- A sharp rise in CEO age: Study
- Gastroenterologists’ incentive bonus picture, a breakdown
- South Carolina enacts bill requiring in-person exams for orthodontic treatment
- The ASC land grab reaches a new ‘level of urgency’
- Plant-Based Diet May Cut Obesity Risk For Women In Menopause
- Qualitas Dental Partners increases credit facilities to fuel acquisitions
- CVS restores coverage of Eli Lilly obesity med Zepbound, adds new pill Foundayo
- CMS finalizes changes to No Surprises Act dispute resolution process
- Smartwatch App Accurately Detects Major Epileptic Seizures
- Racial Gap Exists For Asthma Inhaler Use
- New Colon Cancer Screening Guidelines Add Blood And At-Home Tests
- CVS expands partnership with Salesforce for greater call center personalization
- Wearable Ultrasound Patch Monitors High-Risk Pregnancies In Real Time
- Nurse Convicted In Patient's Death Turns Fatal Drug Error Into Cautionary Tale
- Listen to the Latest ‘KFF Health News Minute’
- In a Vaccine-Skeptical California County, a Potential Playbook To Contain Measles
- Teladoc Health inks partnership with Walmart to expand virtual care services
- PharmaEssentia taps Incyte alum Eric Vogel as it eyes Besremi expansion
- Kaléo speaks up on allergy awareness to amplify patient stories
- 40% of dentists quit AI tools within 90 days: Study
- Privacy and PetShops: Remarks at the Regulatory PETshop Series: Cryptographic Technologies and Financial Services Regulation
- The calm before the storm: 3 policies ASC leaders should be watching
- NYC Health + Hospitals adds 2nd behavioral health housing site
- 12 new cardiac catheterization labs in 2026
- Dental assistant employment hits 387,000: State-by-state breakdown
- Meet the CFOs of 10 specialty DSOs
- Mindfulness isn’t a perk anymore — it’s a workforce strategy
- Pearl launches AI-powered dental RCM platform
- ‘Standardize what protects the patient’: The balancing act in behavioral healthcare operations
- Oregon college launches online dental hygiene program
- With Elahere building steam, AbbVie nets FDA nod for another ImmunoGen cancer asset
- Nebraska behavioral health workforce grew 49% since 2010: 4 notes
- Hospitals again ask FTC, DOJ for exemption from expanded premerger notification filings
- Coalition for Health AI unveils governance playbooks for responsible AI adoption
- 10 behavioral healthcare M&A deals in 2026
- Florida retail property with a Heartland Dental sells for $11M
- 15 notable DSO updates in May
- Maryland psychiatric hospitals strained at 95% capacity: 5 things to know
- Amazon taps Roy Schoenberg to lead healthcare business as Neil Lindsay plans to step down
- Viridian, awaiting FDA decision, taps WuXi Bio in eye drug supply deal
- U.S. To Keep Ebola-Exposed Citizens In Kenya Under New Policy
- FDA clears 1st neuromodulation device for PTSD
- VA expands psychedelic therapy research
- CAT on a Hot Tin Roof
- GLP-1 Meds May Help Slow the Spread of Certain Obesity-Related Cancers
- GoodRx launches subscription program for low-cost generic medications, telehealth services
- George Washington University locks deal to hand off debt-ridden physician practice to UHS
- Humana invests $83M in new Florida pharmacy distribution center
- As J&J separates from its orthopedics business, it's laying off 56 employees in New Jersey
- ASCO preview: With expectations jacked up, Akeso's ivonescimab to face scrutiny in high-stakes plenary
- An insider’s look at LillyDirect
- GLP-1 manufacturer CordenPharma strikes deal for peptide CDMO, lining up new production sites in US and China
- Weight-Loss Program Helps Women Battling Breast Cancer
- Younger U.S. Women of Color Face Rising Breast Cancer Deaths
- High Fitness Doesn’t Raise A-fib Risk In Young Men, Study Finds
- Cheaper, Alternative Health Plans Are Having A Moment, But Critics Urge Caution
- Ultrafine Wildfire Smoke Particles May Pose Serious Health Risks
- Nurse Convicted in Patient’s Death Turns Fatal Drug Error Into a Cautionary Tale
- Montana Hurries To Adopt Trump’s Medicaid Work Rules Amid Budget Woes
- Readers Address Drugged Driving, Suicide Prevention, Worker Shortages
- Amid policy and pricing headwinds, US healthcare and life sci faces 'vast field of opportunity': survey
- Amid policy and pricing headwinds, US healthcare and life sci faces 'vast field of opportunity': survey
- Biogen investigated by Italian regulator over multiple sclerosis ‘market abuse’ claims
- FDA delays ruling on AstraZeneca’s breast cancer drug after negative adcomm vote
- Eli Lilly wins argument over Noom’s GLP-1 dosing claims
- Remarks at the Stanford Rock Center for Corporate Governance
- Eviction ban expirations tied to rise in psychiatric care use: Study
- Smart ring maker Oura files confidentially for IPO as consumer demand propels revenue growth
- Outlook moves toward potential US nod for thrice-snubbed eye drug with FDA appeal win
- JD Power: Cost pressures worsen member experience with commercial plans
- Trinity Health credits pay rates, cost management for its steady 1% operating margin
- Trump Admin Bars Key U.S. Researchers From Global Virus Response Talk
- Listen to the Latest ‘KFF Health News Minute’
- CVS sues to challenge Tennessee's new PBM law
- As calls for COINS Act expansion grow, will new rules sweep up China biotech licensing?
- Radiopharmaceutical outfit Lantheus mulls potential $7B takeover by Curium: Bloomberg
- Everyone Has A Family Doc, But Can You Get An Appointment?
- Many U.S. College Students With Psychosis Are Not Receiving Treatment
- Antibiotics Won't Help Ease Asthma-Linked Wheezing in Kids
- Yoga Eases Insomnia And Anxiety In Cancer Survivors, Study Finds
- SK bioscience links up with Colombia to enable local production of varicella vaccine
- After prior FDA manufacturing snub, Gilead's hepatitis D med Hepcludex nabs US nod
- Dust Yields Clues to Viral Outbreaks, Study Finds
- 3 Medical Routines That Older People May Not Need
- Cheaper, Alternative Health Plans Are Having a Moment, but Critics Urge Caution
- Acadia boosts ‘More To Parkinson's’ campaign with Ryan Reynolds, Parkinson’s voices
- Niowave kicks off construction of $75M radiopharmaceutical isotope plant in Michigan
- Wheel, b.well partner to build turnkey infrastructure behind AI-native virtual care
- Journalists Distill News on Ebola, Licensing Midwives, and California’s Budget
- Trump Bought Stock in Eli Lilly as His Policies Gave the Drugmaker a Big Boost, Documents Show
- Acting NIAID Chief Steps Down Amid Ebola, Hantavirus Concerns
- Sunscreen Confusion Puts More Americans At Risk For Melanoma
- ACAP warns final ACA rule adds further uncertainty to a market in flux
- AbbVie plots 85 summer layoffs tied to Allergan unit in California
- Quorum Health transitioning to nonprofit for financial pickup
- Women's Health Capitol Hill Day: Advocates lobby to advance budget priorities
- Europe's CHMP gives thumbs up to AZ's breast cancer drug after thumbs down from FDA adcomm
- Swoop acquires prescription fulfillment platform Nimble to support independent pharmacies
- 1 In 10 U.S. Surgeons Quit Practice, Study Warns Of Shortage
- Video Game Can Detect Depression In Minutes, Study Says
- Quitting Smoking Might Lower Your Dementia Risk
- Severe Asthma Often Comes With Other Serious Health Problems
- Efforts To Understand The Nation's Drugged Driving Problem Stall Under Trump
- 3 Medical Routines That Older People May Not Need
- Innovaccer picks up CaduceusHealth to offer end-to-end revenue cycle management
- RFK Jr. Fires Two Leaders Of Major U.S. Health Task Force
- Ksana Health awarded $17.9M to build behavioral health foundation model
- Common Food Preservatives Linked to Major Heart Problems
- Migraine With Aura Linked To Middle-Age Stroke Risk
- Nicotine Vapes Triple Smokers' Odds Of Quitting Tobacco
- Fatty Liver Disease Increases Heart Attack Risk, Study Says
- Religious Anti-Abortion Center Finds Opportunity In Town Without OB-GYNs
- CPAP Insurance Rules Too Stringent, Deny Device Coverage To Sleep Apnea Patients Who Would Benefit
- Fixing Eligibility at the Point of Care: The Missing Link in Medical Device Reimbursement Integrity
- Fixing Eligibility at the Point of Care: The Missing Link in Medical Device Reimbursement Integrity
- The failure of the ‘usual suspects’ approach to life science recruitment
- The failure of the ‘usual suspects’ approach to life science recruitment
- Statement on Novel Exchange-Traded Funds (ETFs)
- Value, Focus, and the Future of MedTech: M&A and Divestitures are Rewriting the Strategic Playbook.
- Value, Focus, and the Future of MedTech: M&A and Divestitures are Rewriting the Strategic Playbook.
- Rollback of PFAS Drinking Water Standards Raises Safety Fears
- Designing an agentic, future‑ready tech roadmap for emerging pharma
- The Boston Children’s Experience: Hidden ICU Risk and AI-Driven De-escalation
- The Boston Children’s Experience: Hidden ICU Risk and AI-Driven De-escalation
- How specialty practices can get more out of technology investments
- Artivion Completes Endospan Acquisition, Expands Aortic Arch Portfolio With FDA-Approved NEXUS System
- Artivion Completes Endospan Acquisition, Expands Aortic Arch Portfolio With FDA-Approved NEXUS System
- Your Handwriting Could Be a Window Into Your Aging Brain
- Real-World Evidence in the AI Era: What You Can Unlock Depends on What You Build On
- How Do Caffeine, Alcohol, Weed, Nicotine Affect MS Symptoms?
- Once-A-Day Pill Effective In Treating Sleep Apnea Without CPAP, Clinical Trial Says
- Teens Turning To Creatine, Not Steroids, For 'Looksmaxxing'
- Childhood Trauma Tied to Higher Obesity Risk, But One Caring Adult Can Make A Difference
BridgeMI posted seven stories yesterday on the aftermath of the $ 800 million opioid settlement in Michigan and the festival of greed which has ensued. It is the same sudden windfall/big spending process by which big lottery winners go bankrupt:
Michigan opioid cash sparks feeding frenzy of vendors, seeking cut of $1.5B
By Ron French & Robin Erb - February 7, 2024* Cities and counties in Michigan are in line to receive more about $725 million in opioid settlement funds
* Local officials say they are flooded with product offers nearly every day and have trouble weighing their worth
* Advocates urge Michigan local officials invest in existing community services rather than new gadgetsKatelyn Zeits has become very popular in the past 12 months. The Benzie County administrator has been flooded with emails and phone calls from across the country pitching products for her small county on the shores of Lake Michigan, from out-of-town counseling services to $200,000 body scanners similar to those used in airports.
“They say, ‘Oh, we can use your money like this, this is our equipment, it’s an allowable expenditure (under opioid settlement guidelines),’” Zeits said. “There are so many people out there trying to get a grab of that money.”
Michigan counties, townships and cities are in line to receive about $725 million over 18 years as part of a national settlement of numerous lawsuits against manufacturers, distributors and pharmacies accused of downplaying the risks and ignoring the perils of prescription painkillers, fueling a nationwide opioid crisis.
Combined with money coming into the state, Michigan is in line to receive $1.5 billion total. The state and local governments have already received $181 million, most of it within the past 13 months. From that pot, the tally for local governments is almost $68 million.
From overdose-tracking software to drug test strips, “there’s not a day that really goes by where there isn't some sort of sales email coming to (me),” said Jackson County Health Officer Kristin Pluta.
Advocates hope the money will help curb a crisis that has killed more than 11,000 Michiganders since 2018.
Advocates say the best way to save lives is to expand local services and fill gaps in treatment and recovery. But to do that, local officials more accustomed to road repairs and zoning approvals must navigate through a feeding frenzy of vendors hawking merchandise marketed to capture settlement dollars, said Jonathan Stoltman, director of the Opioid Policy Institute in West Michigan.
“There are so many sharks in the water now because there’s so much money,” Stoltman said.
“I’ve heard (opioid settlement fund pitches for) radar guns to catch speeders, because speeders could be drug dealers,” said Sara Whaley, program director of the Bloomberg Overdose Prevention Initiative at Johns Hopkins Bloomberg School of Public Health. “Any time there are dollar signs, there are for-profit organizations looking for their piece of the pie.”
One example: County officials have been pitched on the purchase of Naloxbox, a plastic container for Narcan. The cheapest model retails for $260, no supplies included. The product is promoted as a “new and innovative way” to expand Narcan access, but Stoltman said it’s an overpriced gadget — “like a Tupperware box that’s bolted onto the wall.”
Benzie County’s Zeits told Bridge a company pushed her to buy a $200,000 body scanner for the county’s 40-person capacity jail.
“They said it’s used in Miami-Dade (Corrections Center),” Zeits said, laughing. “I told them, ‘Have you ever been to Benzie County?’”
Two counties — Kalamazoo and St. Clair — did use opioid settlement funds to buy body scanners for their jails. Kalamazoo County Commissioners Chair John Taylor told Bridge the body scanner is an added safety measure for county inmates who could overdose if they sneak in drugs. A call to St. Clair County Controller Karry Hepting for comment was not returned.
Narcan vending machines are available to Michigan communities at no cost through a program at Wayne State University funded by the Michigan Department of Health and Human Services.
So far, the school has placed 35 machines in 20 counties, according to Danielle Lenz, project coordinator at the Center for Behavioral Health and Justice at Wayne State. Still, there are “multiple vendors who sell these types of machines,” Lenz said, at prices up to $7,400.
Lori Ziolkowski, chapter president of Families Against Narcotics in Bay County, urged local governments to look for simple, inexpensive ways to save lives. Repurposed old newspaper boxes can be set up in public spaces and stocked with Narcan.
One such Narcan newspaper box in downtown Bay City distributes about 100 boxes of the life-saving drug a month, Ziolkowski said.
Recent conferences for county officials hosted by the Michigan Association of Counties included vendors from Deterra, which sells a system to deactivate prescription leftover opioid prescriptions.
Michigan’s health department offers technical assistance for local jurisdictions, and has participated in a series of in-person and online listening sessions to assess local needs, and the Michigan Association of Counties provides an online resource library for local government officials working to figure out how best to spend settlement funds.
“Everyone wants that magic solution. But these dollars are not the opportunity to invest in a pilot program,” said Johns Hopkins’ Whaley. “Getting communities talking to agencies already working on the ground (does more good) than a fancy vending machine.”
The other six BridgeMI stories on the aftermath of the $ 800 million opioid settlement in Michigan are worth your time as well.
And in the way of sudden windfalls, sometimes they disappear.
Medpage Today reports on the SCOTUS decision striking down the Purdue Pharma/Sackler Opioid Settlement.
On the same day Michigan's 2025 budget is announced. Wonder how much of the settlement has already been spent?
https://www.medpagetoday.com/publichealthpolicy/opioids/110851
Supreme Court Rejects Purdue Pharma Settlement That Shielded Sacklers
— In a 5-4 decision, justices blocked an agreement with victims and state and local governments
The Supreme Court on Thursday rejected a nationwide settlement with oxycodone hydrochloride (OxyContin) maker Purdue Pharma that would have shielded members of the Sackler family who own the company from civil lawsuits over the toll of opioids but also would have provided billions of dollars to combat the opioid epidemic.
After deliberating over the case (Harrington v. Purdue Pharma) for more than 6 months, the justices in a 5-4 vote blocked an agreement hammered out with state and local governments and victims. The Sacklers would have contributed up to $6 billion and given up ownership of the company, but would have retained billions more. The agreement provided that the company would emerge from bankruptcy as a different entity, with its profits used for treatment and prevention.
Justice Neil Gorsuch, writing for the majority, said "nothing in present law authorizes the Sackler discharge."
Justices Brett Kavanaugh, Ketanji Brown Jackson, Elena Kagan, and Sonia Sotomayor dissented.
"Opioid victims and other future victims of mass torts will suffer greatly in the wake of today's unfortunate and destabilizing decision," Kavanaugh wrote.
The high court had put the settlement on hold last summer, in response to objections from the Biden administration.
It's unclear what happens next.
"Today's Supreme Court ruling marks a major setback for the families who lost loved ones to overdose and for those still struggling with addiction," Edward Neiger, a lawyer representing more than 60,000 overdose victims, said in a statement.
"The Purdue plan was a victim-centered plan that would provide billions of dollars to the states to be used exclusively to abate the opioid crisis and $750 million for victims of the crisis, so that they could begin to rebuild their lives. As a result of the senseless 3-year crusade by the government against the plan, thousands of people died of overdose, and today's decision will lead to more needless overdose deaths."
An opponent of the settlement praised the outcome.
Ed Bisch's 18-year-old son Eddie, died from an overdose after taking OxyContin in Philadelphia in 2001.
The older Bisch, who lives in New Jersey, has been speaking out against Purdue and Sackler family members ever since and is part of a relatively small but vocal group of victims and family members who opposed the settlement.
"This is a step toward justice. It was outrageous what they were trying to get away with," he said Thursday. "They have made a mockery of the justice system, and then they tried to make a mockery of the bankruptcy system."
He said he would have accepted the deal if he thought it would have made a dent in the opioid crisis.
He's now calling on the Department of Justice to seek criminal charges against Sackler family members.
Arguments in early December lasted nearly 2 hours in a packed courtroom as the justices seemed, by turns, unwilling to disrupt a carefully negotiated settlement and reluctant to reward the Sacklers.
The issue for the justices was whether the legal shield that bankruptcy provides can be extended to people such as the Sacklers, who have not declared bankruptcy themselves. Lower courts had issued conflicting decisions over that issue, which also has implications for other major product liability lawsuits settled through the bankruptcy system.
The U.S. Bankruptcy Trustee, an arm of the Justice Department, argued that the bankruptcy law does not permit protecting the Sackler family from being sued. During the Trump administration, the government supported the settlement.
The Biden administration had argued to the court that negotiations could resume, and perhaps lead to a better deal, if the court were to stop the current agreement.
Proponents of the plan said third-party releases are sometimes necessary to forge an agreement, and federal law imposes no prohibition against them.
OxyContin first hit the market in 1996, and Purdue Pharma's aggressive marketing of it is often cited as a catalyst of the nationwide opioid epidemic, with doctors persuaded to prescribe painkillers with less regard for addiction dangers.
The drug and the Stamford, Connecticut-based company became synonymous with the crisis, even though the majority of pills being prescribed and used were generic drugs. Opioid-related overdose deaths have continued to climb, hitting 80,000 in recent years. Most of those are from fentanyl and other synthetic drugs.
The Purdue Pharma settlement would have ranked among the largest reached by drug companies, wholesalers, and pharmacies to resolve epidemic-related lawsuits filed by state, local, and Native American tribal governments and others. Those settlements have totaled more than $50 billion.
But the Purdue Pharma settlement would have been only the second so far to include direct payments to victims from a $750 million pool. Payouts would have ranged from about $3,500 to $48,000.
Sackler family members are no longer on the company's board, and they have not received payouts from it since before Purdue Pharma entered bankruptcy. In the decade before that, though, they were paid more than $10 billion, about half of which family members said went to pay taxes.
Here come the funds. Even without Purdue Pharma/Sackler, there are plenty of healthcare businesses being scalped paying a boatload of money.
WILX video and related articles available at the link, omitted here due to length.
https://www.wilx.com/2025/07/10/michigan-receives-part-720-million-settlement/
Michigan receives part of $720 million settlement
LANSING, Mich. (WILX) - Eight drug makers are facing nationwide settlements.Michigan Attorney General Dana Nessel making the announcement on Thursday.
The settlement comes as these companies manufactured opioid pills, worsening the nationwide opioid crisis worth around $720 million nationwide.
Michigan could receive up to $24.5 million from that settlement.
“We are seeing firsthand how these opioid settlements are making a real difference in our communities,” Nessel said. “I will continue to work alongside my colleagues across the country to hold these companies accountable and bring meaningful relief to the people and families impacted by this crisis.”
The total amount the eight defendants will pay in funds to address the opioid crisis as part of the deal are:
- Mylan (now part of Viatris): $284,447,916 paid over 9 years
- Hikma: $95,818,293 paid over one to 4 years
- Amneal: $71,751,010 paid over 10 years
- Apotex: $63,682,369 paid in a single year
- Indivior: $38,022,450 paid over 4 years
- Sun: $30,992,087 paid over one to 4 years
- Alvogen: $18,680,162 paid in a single year
- Zydus: $14,859,220 paid in a single year
In addition to these payments, several of the settlements allow states to receive free pharmaceutical products or cash in lieu of this product. Seven of the companies (not including Indivior) are prohibited from promoting or marketing opioids and opioid products, making or selling any product that contains more than 40 mg of oxycodone per pill, and are required to put in place a monitoring and reporting system for suspicious orders. Indivior has agreed to not manufacture or sell opioid products for the next 10 years, but it will be able to continue marketing and selling medications to treat opioid use disorder.
The Attorney General’s Office continues to take action in combatting the opioid crisis, resulting in over $1.6 billion dollars to Michigan governments through settlements with McKinsey & Co, Distributors (Cardinal Health, McKesson, Inc., and AmerisourceBergen), Janssen Pharmaceuticals, Teva Pharmaceutical, Allergan Pharmaceutical, CVS, Walmart, and Walgreens. The money is distributed to the state and local units of government for Opioid-use disorder treatment and remediation.
Analysis of provisional data from the Michigan Department of Health and Human Services (MDHHS) indicates a 34% reduction in overdose deaths between 2023 and 2024 – about 1,000 fewer deaths. This continued progress reflects the impact of sustained, strategic investment in prevention, treatment, recovery, and harm-reduction efforts – many of which are made possible through additional funding received as a result of Michigan’s participation in the national opioid settlements.
Bridge Magazine notes that some of the opioid settlement funds have not yet been spent in some counties. And some of the expenditures charged to the opioid settlement funds have been pretty dubious:
Three years in, funds to fight opioids still unspent in some Michigan counties
By Ron French - March 31, 2026
- Some Michigan communities have been slow to spend money meant to battle the opioid crisis
- A report from the Attorney General’s office will offer more details this spring
- Almost 2,000 Michiganders died from drug overdoses in 2024
More than three years after Michigan communities began receiving millions of dollars to fight the opioid epidemic, some have yet to spend a dime.
Michigan is set to receive at least $1.6 billion over 18 years from a national lawsuit settlement with drug manufacturers, distributors and pharmacies that were deemed partly responsible for the opioid crisis.
The state is getting half that money, with the rest split between Michigan counties, townships and cities. The funds began arriving in January 2023.
While experts say the funds are beginning to make a difference, the sluggish pace of spending in some communities, from the wine country of Grand Traverse County to mid-Michigan’s Eaton County, has frustrated some state leaders.
“If there was some deliberative process that took three years, that’s too long,” said Jonathan Stoltman, of the Grand Rapids-based Opioid Policy Institute. “Money needs to get out the door.”
Settlement funds are meant to help mitigate the continued harm of the opioid crisis, which as recently as 2023 killed nearly 3,000 Michiganders. An estimated 80% of those deaths were opioid-related.
And while overdose deaths declined by a third to 1,938 in 2024, the last year for which the state has complete data, the number of Michigan residents dying from drugs was still higher than the number who died in car crashes.
Despite the crisis, some local governments are only now preparing to begin disbursing funds to community groups that help those battling addiction.
One that has yet to spend any funds is Grand Traverse County, where Traverse City is located, which has about $2 million from the settlement in the bank and is expected to receive $6.2 million overall.
It’s taken time to figure out how to use the one-time funds to best address the crisis, Grand Traverse County Health Officer Mike Lahey told Bridge Michigan.
“I think some localities, while appreciating (the funds), were like, ‘Now what?’” Lahey said. “It was a new source of money with new types of parameters around it.”
Awaiting a full accounting
It’s unclear how much of the settlement funds distributed to Michigan communities since 2023 have been spent. A 2024 Bridge investigation provided the first statewide accounting of how communities were handling those funds. That investigation found that more than 40% of communities had not spent any funds, with about $90 million sitting in bank accounts.
That closely matched the findings of a survey conducted in the spring of 2025 by the Michigan Association of Counties. Of the 36 counties that responded, 40% had yet to open their checkbooks. That was an improvement from 2024, when a similar survey found 51% hadn’t spent money.
Michigan soon may have a more authoritative accounting.
The Michigan Department of Attorney General has asked counties, townships and cities receiving opioid settlement funds to report how they’ve been spent. Those findings are expected to be released this spring, according to Danny Wimmer, a spokesperson for Attorney General Dana Nessel.
Eaton County is among communities yet to distribute funds. The county, which is receiving about $300,000 annually, has “developed a strategic plan and a community assessment to identify gaps in mitigation efforts,” Logan Bailey, director of public and governmental affairs for the county, said in an email to Bridge. “We are still in a planning/assessing/collecting RFPs stage.”
Officials in Lenawee County, which borders Ohio, will consider $1.25 million in proposals for its first opioid settlement spending in April, according to Community Development Coordinator Francine Zysk.
Isabella County, which has $1.1 million in settlement funds in the bank, expects to spend its first settlement funds in 2026. Meanwhile, Schoolcraft County in the Upper Peninsula is just now forming a committee to make spending recommendations.
The city of Warren had $2.9 million in opioid settlement funds in the bank as of October, and had not disbursed any.
“There are those who are anxious to push dollars out without fully considering community needs, process, best practices, or long-term impact,” Mayor Lori Stone said in an October news release. “Opioid use, substance use disorder, and addiction will continuously affect our community. My goal is to find a way of generating continuous revenue that can be dedicated to addressing these ongoing needs.”
Warren officials did not respond to a request for an update on opioid settlement spending
Cara Poland, chair of the Michigan Opioid Advisory Commission, which makes recommendations to the Legislature, agrees that communities should be thoughtful about how they spend settlement dollars.
But after more than three years, “planning time has been adequate,” Poland told Bridge. “We should be (using) those funds.”
A ‘very frustrating process’
In Grand Traverse County, spending was slowed by a failed first attempt to create a plan for the money, said county health officer Lahey. Now, a plan is in place and a task force formed. “I hope to have (requests for proposals) out in May,” he said.
The process has moved too slowly, said Pam Lynch, of the Traverse City-based Harm Reduction Michigan.
“It’s been a very frustrating process for people who have been doing effective work for a long time,” said Lynch.
“I hear the criticism. ‘What are we doing — this money should be out.’” Lahey said. “And I get it.
“There are only so many chips to pass around the table,” he said. “It sounds like a lot of money. But when you start talking about building programs and hiring people, a million dollars can go fast.”
With the state’s half of settlement dollars, the Michigan Department of Health and Human Services is distributing $131 million this budget year for drug prevention, treatment and recovery services around the state.
One success story: Since 2023, Michigan has spent $14.8 million in settlement money for 424,882 kits of naloxone, commonly known by the brand name Narcan, which is used to revive people who have overdosed on opioids. Organizations can request the kits for free from the state, and in many communities, drug users can then pick up free kits in vending machines and converted newspaper boxes.
That effort is credited at least in part for the decline of almost 1,000 overdose deaths in Michigan from 2023 to 2024.
“When someone uses naloxone, they may be reachable for treatment,” said Poland, chair of the Opioid Advisory Commission. “You don’t have a chance for recovery when someone overdoses and dies.”
Stoltman of the Opioid Policy Institute is eager for settlement funds to be spent, but he also worries that some communities have used the funds for things that don’t address the crisis.
Recently, Flint spent $25,000 in settlement funds to pay for a sign-language interpreter at city council meetings. Farmington Hills used $120,000 to backfill its budget, arguing it was to replace money spent on the drug crisis in the past.
“The best case scenario is that folks (who have yet to spend settlement dollars) are scared to mess it up,” Stoltman said. “But in your fourth year, you can’t be too scared to spend it.”
My calculator says that 424,882 naloxone kits for $ 14.8 million amounts to $ 34.83 per kit.
Bridge Magazine follows up on their opioid settlement funds reporting:
Michigan cities, counties have spent 18% of opioid settlement funds
By Ron French - May 15, 2026
- Local Michigan governments have $176 million in the bank to fight the opioid crisis
- A dozen counties haven’t spent any funds yet, but that may change this year
- A new report from the Attorney General’s Office is the first official accounting of opioid settlement spending
Michigan towns, cities, townships and counties have $176 million sitting in bank accounts meant to fight the state’s opioid crisis.
The state’s first official accounting of spending by local governments of opioid settlement funds, produced by the Michigan Attorney General’s Office, found that 17.7% of funds received since checks began arriving three years ago had been spent by mid-December 2025.
The funds — Michigan’s share of national settlements with drug manufacturers and distributors for their role in sparking the opioid crisis — are meant to help mitigate drug use and deaths. On average, a Michigander dies every six hours from an opioid overdose, with about 2,000 dying last year.
Michigan governments are slated to receive nearly $1.8 billion from opioid settlements by 2040. Half of the settlement amount will be distributed directly to county, city, and township governments, with the rest distributed to the state for drug prevention services.
The report, released Thursday, was a breakthrough in itself. Bridge reporting in 2024 revealed that, unlike other states, Michigan was not tracking how local governments were spending what would eventually amount to more than $700 million. That decision made it difficult for residents to know how much money was being spent and on what.
Using Freedom of Information Act requests, Bridge found that, as of September 2024, local governments were sitting on $90 million, with four in 10 communities having not spent any of their funds yet.
A year later, the Attorney General’s Office renegotiated its agreement with local communities to require communities to file reports on how funding was being spent.
Thursday’s report offered the first look at that spending.
“The opioid epidemic has caused immense damage to Michigan families and communities,” said Attorney General Dana Nessel in a news release. “By providing spending guidance and accessible data, we are helping ensure that settlement funds remain focused on supporting recovery, prevention, and healing across our state.”
According to the report:
- Through Dec. 10, local governments — cities, towns, townships and counties — had received $214 million in opioid settlement funds, and spent $38 million.
- Of 258 local governments that reported spending to the attorney general, 75 (2%) had not spent any funds.
- Twelve counties, all in northern Michigan or the Upper Peninsula, have yet to spend funds.
- Among cities, Warren (with $2.7 million in the bank) and Farmington Hills ($1.7 million) hadn’t spent funds as of December.
Amy Dolinky, technical adviser for opioid settlement funds planning and capacity building at the Michigan Association of Counties, told Bridge that some of the counties that had not spent opioid funds as of December have recently completed planning and are preparing to disburse money in 2026.
“We had advised local governments to think through sustainable funding, and with that in mind, a lot of governments put more planning on the front end,” Dolinky said. “We’ll see more spending going forward.”
Drug deaths have dropped sharply in Michigan, with about 1,700 deaths in 2025, the lowest figure since 2013. As recently as 2021, there were 3,096 overdose deaths.
Experts attribute the decline in part to the widespread use of naloxone, which is used to revive those suffering from opioid overdoses. The state has distributed more than 1.7 million naloxone kits since 2020 and recorded more than 34,000 overdose reversals, according to a new report by the Michigan Opioid Task Force.
The press release from AG Nessel's office referred to by Bridge Magazine:
https://www.michigan.gov/ag/initiatives/opioids
https://www.michigan.gov/ag/initiatives/opioids
AG Nessel Releases Opioid Settlement Spending Guidance and Report
By Danny Wimmer - May 14, 2026LANSING – Today, Michigan Attorney General Dana Nessel announced the addition of an opioid settlement report and spending guidance to the Department of Attorney General’s website to strengthen transparency in how opioid settlement funds are used across the state. In July 2025, the Department of Attorney General and the 86 Michigan Litigating Local Governments negotiated a revised State-Subdivision Agreement for Opioid Settlements. The revised agreement requires an annual report, enables the Department of Attorney General to issue general guidance about opioid settlements, and clarifies the Department of Attorney General’s ability to request information about opioid settlements from participating local governments. The two resources released today follow that revised agreement and are designed to support the effective use of settlement funds.
“The opioid epidemic has caused immense damage to Michigan families and communities,” said Attorney General Nessel. “By providing spending guidance and accessible data, we are helping ensure that settlement funds remain focused on supporting recovery, prevention, and healing across our state.”
The Settlement Spending Guidance and Non-Remediation List provides a framework for local governments to follow when allocating opioid settlement funds. Utilizing existing guidance and evidence, the webpage outlines recommended uses and includes a list of expenditures that likely do not qualify as opioid remediation, which will continue to be updated.
The Opioid Received/Expended Report, located on the opioid settlements webpage, compiles data submitted by local governments detailing how much opioid settlement funding a local government has received and how those funds have been spent. The preliminary report covers data compiled from January 1, 2023, to December 10, 2025, and will continue to be updated as additional local governments submit reports to the Department of Attorney General.
Since taking office in 2019, Attorney General Nessel has prioritized combating the opioid epidemic and holding accountable those responsible for creating and fueling the crisis. Her efforts have resulted in more than $1.8 billion in settlements for Michigan governments. For more information, visit the Opioids Settlement webpage.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.















